Einspahr, David

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Garassino, M. C., Cho, B.-C., Kim, J.-H., Mazières, J., Vansteenkiste, J., Lena, H., Corral Jaime, J., Gray, J. E., Powderly, J., Chouaid, C., et al. (2018) · The Lancet Oncology

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 568

Intact transferrin receptors in human plasma and their relation to erythropoiesis

Huebers, H., Beguin, Y., Pootrakul, P., Einspahr, D., & Finch, C. (1990) · Blood

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 364